![](/img/cover-not-exists.png)
DOP53 Clinical, endoscopic, histological and biomarker activity following treatment with the gut-selective, pan-JAK inhibitor TD-1473 in moderately to severely active ulcerative colitis
Sandborn, W, Nguyen, D, Ferslew, B, Hao, L-Y, Kanno, T, Tomsho, L, Boyle, D, Graham, R, Abhyankar, B, Panes, JVolume:
13
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.087
Date:
January, 2019
File:
PDF, 377 KB
2019